A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
Clinical trial NCT03093272 · TERMINATED
Trial details
- NCT number
- NCT03093272
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-23
- Primary completion
- 2019-05-16
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.